|
|
||||
| Email This Page to Friend | |||||
Osteoarthritis is a degenerative form of arthritis. The joints in the body are composed of bone, which are covered with a smooth layer of cartilage. If you have a family history of osteoarthritis then you have a higher chance of developing the disease yourself. Besides genetic predisposition, osteoarthritis can be present in those who are overweight or those who routinely put stress on the particular joint. Injury is also a culprit.
Osteoarthritis affects the joints in the body, most commonly the spine, hips, knees, feet and hands. It is caused by the wearing down of cartilage between these joints, causing bones to rub together. This causes discomfort and a decrease in mobility to the area. Symptoms of osteoarthritis are generally limited to the joint involved. Patients usually experience pain when they use the joint and the symptoms go away with rest. Patients may have some stiffness, when they first use a joint. If the arthritis is severe, patients may lose functional capacity in the joint that has osteoarthritis.
Osteoarthritis is the most common form of arthritis, affecting 21 million people in the United States. It can be caused by a number of factors. While it is more frequently found in those over 45, it can occur in younger people. Under 45, men are more likely to develop the disease than women, while over 45 women are more likely to develop it than men.
Fortunately, there are ways to prevent the onset of the disease, and it's easier than you think. It's about taking care of your body, which hopefully you're doing already as good health is the key to combating any form of disease, as well as education.
If you are overweight you are far more likely to develop osteoarthritis than someone who isn't. This is because the extra weight puts unnecessary stress on the joints. Keeping in shape also helps to prevent many other diseases, such as heart disease.
Keep fit, not only to keep your weight in healthy range but also to work your joints. Aerobic exercises that work as much of your body are especially important; they revitalize your circulatory system and keep your heart rate up, as well as keep your joints limber. Make sure not to over exert yourself, especially if you feel pain in a joint, as this may only cause to exacerbate the condition you are trying to prevent. Discuss with your doctor what kinds of exercises are best for you. Osteoarthritis in the hands is the most genetically predispositioned form of the disease, so if you are at risk ask your doctor if there is anything you can do.
Injury to the joints can also cause the onset of osteoarthritis. Be sure to wear protective gear, like wrist guards for instance, when deemed necessary.
There have been some foods and supplements that have been reported to decrease your chances of getting the disease. While some initial results have proved encouraging, studies are still continuing for conclusive results. None of the supplements have been reported to carry side effects though, and are part of a healthy lifestyle.
An anti-inflammatory is just what you're looking for. Anti-inflammatory properties can be found in Omega-3 fatty acids, which are found in fatty fish like salmon or albacore tuna. Since our North American diet is severely lacking in fish on a regular basis, try an Omega-3 fatty acid supplement such as Omega Daily.
Early detection is important. If you feel a recurring pain in your joints, or a stiffness that won't go away, talk to your doctor. He or she can help you find the best way to deal with the pain.
Rheumatoid Arthritis, or RA, is an autoimmune disorder, causing your immune system to attack the joints, causing a painful inflammation. Unlike other forms of arthritis like osteoarthritis, RA also attacks the organs like the heart, eyes and lungs. Of the 100+ forms of arthritis, this is one of the most debilitating varieties.
Rheumatoid Arthritis affects 1 out of 100 North Americans, or 2.1 million people, and women are three times more likely to get the disease than men. The cause of RA is unknown, but a popular theory points to the disease being infectious as those who have close friends or family with the disorder are more likely to develop it themselves. Susceptibility to the disease may also be an inherited trait as well.
Early detection is vital in treating RA because the most damage is done within the first two years, with 75% of the damage occurring within the first five years. While there is no cure or preventative measure for rheumatoid arthritis, there are a number of treatments to alleviate symptoms. Each type of drug includes its own side effects- make sure that you are informed about the medication you are taking, and report any side effects to your doctor.
Non-Steroidal Anti-Inflammatory Drugs, or NSAIDs, reduce the pain and swelling of the joints. Many can be had without a prescription, like acetylsalicylic acid and ibuprofen. In more severe cases your doctor can prescribe a stronger NSAID. Omega-3, found in fatty fish, also works to shorten the period of stiffness in the morning, one of the major symptoms of rheumatoid arthritis. Add salmon or albacore tuna to your diet, or try an Omega-3 supplement like Omega Daily.
Disease-Modifying Anti-Rheumatic Drugs, known as DMARDs, are slow-acting and may take weeks to take effect. While NSAIDs are effective in relieving pain short term, DMARDs are a long term treatment meant to reduce damage to the joint and bone. Methotrexate is the most widely used DMARD.
There are a number of things you can do yourself to make living with the disease easier. While it is tempting to put as little exertion on your sore joints as possible, keeping active is essential to enjoying life with rheumatoid arthritis. This is for a number of reasons. The first is that regular exercise strengthens the muscles around the joint and increases flexibility. Try low-impact activities, like swimming. Try not to partake in any activities that involve too much exertion, which causes more harm than good. Use heat and cold to your advantage, easing pain. Heat should be applied only when the joint is not inflamed, and preferably in the form of a bath or hot shower. Use cold packs on the inflamed joint directly or after strenuous use of the joint.
|
Arthritis News
|
||||
|
3 Oct 2008 at 12:42pm Reuters - People with rheumatoid arthritis (RA) who have more fat on their arms and legs suffer more disability from the disease, according to the first study to look at how fat and lean mass affect body function in RA patients. 3 Oct 2008 at 11:30am Reuters - Scientists have pinpointed three genes related to the high blood levels of uric acid that cause gout in a step that could help identify people at special risk for this common and painful type of arthritis. 2 Oct 2008 at 10:46pm HealthDay - THURSDAY, Oct. 2 (HealthDay News) -- Resistance training improves muscle strength and physical functioning while decreasing pain in many people with knee osteoarthritis, a new report says. 2 Oct 2008 at 10:46pm HealthDay - THURSDAY, Oct. 2 (HealthDay News) -- How fat and muscle are distributed throughout the body is one of the factors that contribute to limited mobility of people rheumatoid arthritis, a new study finds. 2 Oct 2008 at 12:21pm Reuters - Before newer, more effective drugs became available for treating rheumatoid arthritis, more than half of patients with the condition required orthopedic surgery, including a joint replacement in many cases, Swedish researchers report. 1 Oct 2008 at 10:46pm HealthDay - TUESDAY, Sept. 30(HealthDay News) -- Three genes may raise risks for painful gout by up to 40 times, researchers report. 30 Sep 2008 at 10:46pm HealthDay - TUESDAY, Sept. 30 (HealthDay News) -- Adding occupational therapy to a structured exercise program increases physical activity for most people who have hip and knee osteoarthritis, say researchers. 30 Sep 2008 at 10:46pm HealthDay - TUESDAY, Sept. 30 (HealthDay News) -- The popular supplements glucosamine and chondroitin are no better than a placebo at preventing cartilage loss in knees of people with the form of arthritis caused by wear and tear, a new study found. 29 Sep 2008 at 10:46pm HealthDay - MONDAY, Sept. 29 (HealthDay News) -- The pain caused by osteoarthritis may be as damaging as the disease itself, according to a new study. 29 Sep 2008 at 3:26pm Reuters - Two hugely popular supplements used to fight arthritis and joint pain, glucosamine and chondroitin sulfate, do not seem to work any better than placebo to slow the loss of knee cartilage in osteoarthritis, researchers reported on Monday. |
6 Oct 2008 at 7:00am PanGenetics B.V. announced today that the company has received formal regulatory approval to initiate clinical evaluation of the company's CD40 antagonist antibody, PG102. The multi-centre trial in Hungary and Serbia will recruit patients with active psoriatic arthritis, and is designed as a double blind, placebo controlled, single ascending dose study. The primary objective of the Phase I study is to evaluate the safety and tolerability of PG102. 6 Oct 2008 at 2:00am Using computer models and live cell experiments, biomedical engineers at the Johns Hopkins University School of Medicine have discovered more than 100 human protein fragments that can slow or stop the growth of cells that make up new blood vessels. 4 Oct 2008 at 2:00am A team of researchers from the United States and the Netherlands has identified mutations in three genes that are associated with high levels of uric acid in the blood, which is a risk factor for gout. The team developed a genetic risk score composed of the number of uric acid-increasing mutations that each person carries (0 to 6), which was associated with up to a 40-fold increased risk for developing gout when comparing persons at lowest and highest risk. 3 Oct 2008 at 5:00am At Cambridge Healthtech Institute's Third Annual Drug Repositioning Summit on Monday, October 6 in Boston, the audience is scheduled to hear, as a Keynote Presentation, the story of how an individual physician has charted an entirely new course for a therapeutic which is already one of the most successful of all time. 3 Oct 2008 at 3:00am Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technologyâ„¢, announced today a paper appearing in the advance online publication of Molecular Therapy which describes the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs) in the treatment of rheumatoid arthritis in a murine model of arthritis. 1 Oct 2008 at 11:00am Biotechnology company Arana Therapeutics Limited (ASX: AAH) announced it has submitted an Investigational New Drug application (IND) to the FDA (U.S. Food and Drug Administration) for the anti-inflammatory product ART621 in a rheumatoid arthritis (RA) indication. The IND includes a Phase II dose ranging study of ART621/221 in RA which is planned to be an international multi-centred trial of approximately 200 patients. 1 Oct 2008 at 10:00am VGX Pharmaceuticals, a biopharmaceutical company that is developing DNA vaccines for cancer and HIV and therapeutics for other diseases, announced today the results of a Phase I single ascending dose (SAD) study that demonstrated that its lead anti-inflammatory compound, VGX-1027, was generally safe and well tolerated in humans. As a result, VGX Pharmaceuticals and VGX International, a Korean affiliate that is jointly developing VGX-1027, have commenced a multiple ascending dose (MAD) study. 1 Oct 2008 at 2:00am US scientists found that the dietary supplements glucosamine and chondroitin sulfate were no more effective than placebo at slowing down the rate of cartilage loss in the knees of patients with osteoarthritis; however they also said the trial was probably too short and too small, and spoke more to scientists about how to conduct further research in this area than than to patients. The two-year multicenter study was the work of rheumatologist Dr Allen D. 30 Sep 2008 at 4:00am In a two-year multicenter study led by University of Utah doctors, the dietary supplements glucosamine and chondroitin sulfate performed no better than placebo in slowing the rate of cartilage loss in the knees of osteoarthritis patients. This was an ancillary study concurrently conducted on a subset of the patients who were enrolled in the prospective, randomized GAIT (Glucosamine/chondroitin Arthritis Intervention Trial). 30 Sep 2008 at 4:00am Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism. More specifically, the study revealed that pain signals originating in arthritic joints, and the biochemical processing of those signals as they reach the spinal cord, worsen and expand arthritis. 29 Sep 2008 at 11:00am Physical activity is the cornerstone of any healthy lifestyle - and especially for people with osteoarthritis as exercise helps maintain good joint health, manage their symptoms, and prevent functional decline. Osteoarthritis, however, often makes physical activity, such as exercise, and even performing daily activities, a challenge. 25 Sep 2008 at 3:00am It has long been known that environmental factors play a part in the development of rheumatoid arthritis; smoking and drinking alcohol, along with heredity, are particularly instrumental in increasing the risk of the disease. Scientists at Karolinska Institutet have now produced results that suggest that working environment factors can also increase the chances of developing rheumatoid arthritis. 24 Sep 2008 at 2:00pm HCV is acquired by intravenous drug abuse, sexually or via blood transfusion (rare nowadays due to the effective screening of blood products before transfusion). HCV is known to cause chronic infection in 80% - 90% of the patients becoming infected. Patients present with varying degrees of altered liver function ranging from mild cirrhosis to necrosis (liver cell death). 23 Sep 2008 at 3:00pm Wyeth announced study results from last week's 15th Paediatric Rheumatology European Congress (PRES) in London which highlight the safety record of etanercept (ENBREL(R)) as a continuous therapy in children and adolescents with juvenile idiopathic arthritis (JIA).(1) The study was designed to evaluate the safety of ENBREL in children with polyarticular or systemic JIA. 23 Sep 2008 at 7:00am UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers. |
30 Sep 2008 at 5:30pm BETHESDA, Md. (MedPage Today) -- A genetic risk score based on three genes that influence serum levels of uric acid are associated with a 40-fold increased risk for gout, investigators here reported. 30 Sep 2008 at 1:59pm SALT LAKE CITY (MedPage Today) -- Glucosamine and chondroitin sulfate, individually or in combination, were ineffective in reducing long-term radiographic progression of knee osteoarthritis, showed a large randomized trial. 11 Sep 2008 at 2:40pm ROCKVILLE, Md. (MedPage Today) -- A rheumatoid arthritis patient treated with rituximab (Rituxan) was diagnosed with progressive multifocal leukoencephalopathy (PML) 18 months after taking the last dose of the agent, and later died, the FDA and drugmakers announced today. 11 Sep 2008 at 11:21am HANOVER, N.H. (MedPage Today) -- For patients with a herniated disc, surgery proved a cost-effective alternative to nonsurgical treatment over the course of two years, an observational study found. 5 Sep 2008 at 2:49pm WICHITA, Kan. (MedPage Today) -- Patients with rheumatoid arthritis, particularly those with severe disease, have an increased risk of stroke, according to researchers here. 5 Sep 2008 at 11:51am BOSTON (MedPage Today) -- Ibuprofen use was associated with increased cardiovascular risk in several subgroups of older patients, but not in those with rheumatoid arthritis, researchers found. 4 Sep 2008 at 3:20pm ROCKVILLE, Md. (MedPage Today) -- The FDA announced today that it will require makers of tumor necrosis factor-alpha (TNF) blockers to strengthen warnings about serious fungal infections, particularly histoplasmosis. 20 Aug 2008 at 4:00pm CINCINNATI (MedPage Today) -- Disease flares in children with polyarticular-course juvenile rheumatoid arthritis were significantly reduced by adalimumab (Humira) with or without methotrexate, researchers here reported. 18 Aug 2008 at 4:00pm BELMONT, Mass. (MedPage Today) -- The ADVANTAGE trial comparing Merck's rofecoxib (Vioxx) with naproxen (Aleve) was designed and executed primarily for marketing purposes, said researchers here. 29 Jul 2008 at 6:00pm DAVIS, Calif. (MedPage Today) -- For patients with knee osteoarthritis, an extract of the Indian frankincense plant gave significant pain relief and reduced levels of a marker of joint pathology, researchers here said. 24 Jul 2008 at 5:26pm ATLANTA (MedPage Today) -- Early, aggressive treatment of rheumatoid arthritis with biologic agents and potent drug combinations has moved front and center in the American College of Rheumatology practice guidelines. 15 Jul 2008 at 5:30pm LEEDS, England (MedPage Today) -- Combining methotrexate and etanercept (Enbrel) for early moderate-to-severe rheumatoid arthritis improved remission and progression rates within a year, a randomized trial found. 14 Jul 2008 at 5:07pm GENOA, Italy (MedPage Today) -- Children with idiopathic arthritis unresponsive to other drugs improved on abatacept (Orencia) compared with those given a placebo, a randomized withdrawal trial found. 14 Jul 2008 at 3:00pm BOSTON (MedPage Today) -- Older patients who had hip or knee replacement for severe osteoarthritis took several weeks to recover but had excellent long-term outcomes, a prospective study found. 2 Jul 2008 at 2:18pm NANJING, China (MedPage Today) -- In patients with severe combined lupus nephritis, multitargeted immune therapy led to more than a six-fold increase in the rate of complete remissions compared with intravenous cyclophosphamide, investigators here reported. 3 Oct 2008 at 2:00am Title: Resistance Training Boosts Mobility in Knee Arthritis Patients Category: Health News Created: 10/3/2008 2:00:00 AM Last Editorial Review: 10/3/2008 3 Oct 2008 at 2:00am Title: Body Fat, Muscle Distribution Linked to RA Disability Category: Health News Created: 10/3/2008 2:00:00 AM Last Editorial Review: 10/3/2008 2 Oct 2008 at 2:00am Title: Shoulder Bursitis Category: Diseases and Conditions Created: 12/31/1997 Last Editorial Review: 10/2/2008 1 Oct 2008 at 2:00am Title: Bursitis of the Knee Category: Diseases and Conditions Created: 12/31/1997 Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: MCTD vs. UCTD Category: Doctor's Views Created: 4/19/2001 Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: Diabetes and Foot Problems Category: Diseases and Conditions Created: 1/31/2005 4:24:00 AM Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: Occupational Therapy Plus Exercise Benefits Osteoarthritis Category: Health News Created: 10/1/2008 2:00:00 AM Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: Media Doesn't Often Mention Pharma Funding on Research Category: Health News Created: 10/1/2008 2:00:00 AM Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: Three Genes Raise Gout Risk Category: Health News Created: 10/1/2008 2:00:00 AM Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: Knee Arthritis: Supplements May Not Help Category: Health News Created: 10/1/2008 Last Editorial Review: 10/1/2008 1 Oct 2008 at 2:00am Title: 2 New Gout Genes Discovered Category: Health News Created: 10/1/2008 Last Editorial Review: 10/1/2008 30 Sep 2008 at 2:00am Title: Headache Category: Diseases and Conditions Created: 5/31/2002 Last Editorial Review: 9/30/2008 |
by Arthritis News From Medical News Today 1 Oct 2008 at 9:00am VGX Pharmaceuticals, a biopharmaceutical company that is developing DNA vaccines for cancer and HIV and therapeutics for other diseases, announced today the results of a Phase I single ascending dose (SAD) study that demonstrated that its lead anti-inflammatory compound, VGX-1027, was generally safe and well tolerated in humans. As a result, VGX Pharmaceuticals and VGX International, a Korean affiliate that is jointly developing VGX-1027, have commenced a multiple ascending dose (MAD) study. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 25 Sep 2008 at 2:00am It has long been known that environmental factors play a part in the development of rheumatoid arthritis; smoking and drinking alcohol, along with heredity, are particularly instrumental in increasing the risk of the disease. Scientists at Karolinska Institutet have now produced results that suggest that working environment factors can also increase the chances of developing rheumatoid arthritis. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 23 Sep 2008 at 6:00am UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 23 Sep 2008 at 2:00am Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that in the U.S. rheumatoid arthritis prevalence is lower among Asians and higher among American Indians, compared with the prevalence among Blacks and Whites. The new analytics tool entitled PatientFinder: Rheumatoid Arthritis also reveals that rheumatoid arthritis prevalence in the U.S. varies by how urban or rural the population is. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 17 Sep 2008 at 3:00am 2008 World Congress on Osteoarthritis. September 18 - 21, 2008 Rome Marriott Park Hotel Rome, Italy. 2009 OARSI World Congress has an exciting programe featuring speakers from around the world. This year's opening-day session will feature plenary sessions devoted to a comprehensive overview of current clinical trials for osteoarthritis, outcomes, and the current exciting basic science that fuels the endeavor to make a difference in patients' lives. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 4 Sep 2008 at 3:00am Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that Dr. Leonard S. Schleifer, President and Chief Executive Officer of Regeneron, and other members of senior management will host a webcast conference call commencing at 8:30 a.m. Eastern Time on Wednesday, September 3, 2008. Dr. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 3 Sep 2008 at 3:00am Many health problems can be effectively treated and managed if they are caught early enough. But until now, diagnosing the early stage of osteoarthritis - the often cripplingly painful disease that causes damage to the joints and is thought to affect around 8.5m Brits - has been tricky. That's because diagnosis currently relies on x-ray evidence and physical examination, both of which may not spot signs of the disease until it's in its later stages. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 21 Aug 2008 at 1:00am Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that it has acquired an oral, once-daily candidate for the treatment of rheumatoid arthritis (RA) which has completed a 160 patient, multi-center, double-blind, randomized, placebo-controlled Phase II clinical trial for the treatment of rheumatoid arthritis (RA). (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 13 Aug 2008 at 2:00am For the first time in the United States, more than 200 scientists from around the world will gather to explore research challenging conventional theories about immunology, inflammation and their link to acute and chronic diseases. The Damage Associated Molecular Pattern Molecules (DAMPs) and Alarmins Symposium will be held at the Hillman Cancer Center, 5115 Centre Ave., Pittsburgh, Aug. 30 through Sept. 2. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 12 Aug 2008 at 3:00am Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced the publication of the results of three studies which supported the U.S. Food and Drug Administration (FDA) regulatory submission for ARCALYST® (rilonacept) Injection for Subcutaneous Use for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS). Two studies were published in the August 2008 issue of Arthritis and Rheumatism, the flagship publication of the American College of Rheumatology. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 7 Aug 2008 at 3:00am B cells, the source of damaging autoantibodies, have long been thought to depend upon T cells for their activation and were not considered important in the initiation of autoimmune diseases like lupus or rheumatoid arthritis. In the Aug. 7 online issue of the journal of Immunity, Yale University researchers turn this paradigm on its head by showing that in systemic autoimmune diseases B cells can be activated the absence of T cells. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 7 Aug 2008 at 2:00am Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 89 percent of surveyed rheumatologists anticipate prescribing Roche/Chugai's Actemra, following the expected launch of the drug for rheumatoid arthritis in 2009. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 30 Jul 2008 at 3:00am Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of ACTEMRA(R) (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody, for reducing the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA). (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 23 Jul 2008 at 3:00am Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab), following the use of one anti-TNF, for this debilitating disease. (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 18 Jul 2008 at 1:00am For patients with active, early stage, moderate-to-severe rheumatoid arthritis, a combination treatment with methotrexate and etanercept can improve remission and radiographic non-progression rates within one year in comparison with just methotrexate. Additionally, more patients are also able to remain employed. These conclusions are published in an article released early Online on July 16, 2008 in The Lancet. (Source: Arthritis News From Medical News Today) |
6 Oct 2008 at 11:59am An abnormal signaling pathway that appears to be highly specific to juvenile myelomonocytic leukemia could allow for more rapid and accurate diagnosis and targeted therapies. Medscape Medical News 6 Oct 2008 at 1:00pm A new analysis shows that race and socioeconomic status have a significant affect on patient survival in head and neck cancer, even after adjustment for other factors Medscape Medical News 6 Oct 2008 at 2:43pm The gene for interleukin 10, an immunosuppressive cytokine, plays a clear role in ulcerative colitis susceptibility. Medscape Medical News 6 Oct 2008 at 4:00pm A study shows that implementation of various simple interventions decreases narcotic-related adverse drug events in hospitalized children. Medscape Medical News 6 Oct 2008 at 4:00pm A population-based case-control study shows that the incidence of sudden infant death syndrome may be reduced by using a fan in an infant's sleeping environment. Medscape Medical News 6 Oct 2008 at 4:00pm Tiotropium improves quality of life and multiple parameters of lung function but does not slow decline in forced expiratory volume in 1 second in patients with chronic obstructive pulmonary disease. Medscape Medical News 6 Oct 2008 at 4:00pm In an observational study, use of procalcitonin was effective in detecting serious bacterial infections in young febrile infants, especially in detecting the most serious occult infections. Medscape Medical News 6 Oct 2008 at 9:56am A randomized trial of continuous positive airway pressure in patients with coronary artery disease and obstructive sleep apnea reveals that an unexpectedly high percentage have no symptoms of daytime sleepiness. Medscape Medical News 6 Oct 2008 at 10:34am Independent mutations in a newly identified gene, EYS, are present in unrelated families with retinitis pigmentosa. Medscape Medical News 6 Oct 2008 at 9:40am African American women who are obese are 41% more likely than their slimmer counterparts to be depressed, according to new research from the Centers for Disease Control and Prevention. Medscape Medical News 6 Oct 2008 at 9:53am Two surveys of nearly 35,000 adults with asthma show that almost all patients were awakened at least once a month by asthma symptoms, and three quarters were awakened at least once a week. Medscape Medical News 4 Oct 2008 at 11:32pm Twice as many uninsured people in the United States will have health insurance in 10 years under Sen. Barack Obama's healthcare plan than under Sen. John McCain's plan, according to a report by the Commonwealth Fund, but a critic challenges the group's projections. WebMD Health News 6 Oct 2008 at 11:52am Frequent severe episodes of hypoglycemia associated with intensive diabetes treatment do not adversely affect cognitive function in adolescents with type 1 diabetes, according to findings from the Diabetes Control and Complications Trial (DCCT). Reuters Health Information 6 Oct 2008 at 11:56am American Indians have a higher incidence of stroke compared with white or black Americans, and they are more apt to die from a first stroke, according to a study published online September 22 in Circulation: Journal of the American Heart Association. Reuters Health Information 6 Oct 2008 at 11:24am Inhibition of melanogenesis sensitizes melanoma cells in culture to gamma radiation, according to a report in the September 15th International Journal of Cancer. Reuters Health Information |